Continued Momentum in HCIT Equity Capital Markets
- Equity markets continue to provide growth capital and liquidity opportunities for blue-chip HCIT companies
- We served as active bookrunner on three of 2019's successful HCIT equity offerings
- We served as bookrunner for 70% of our more than 50 healthcare equity offerings since 2018
Trusted Buy-Side Advice to Clients
- Our deep insight across the HCIT landscape provides invaluable buy-side intelligence to our private equity clients
- Financial sponsors value our thoughtful, post-deal potential acquisition roadmaps
- Drawing on multiple decades of transaction structuring and execution experience, we guide buyers in optimizing valuation and terms
- Clients often use our significant leveraged finance capabilities to enforce speed, efficiency, and certainty of transaction debt financing
Established Sell-Side M&A Leadership
- Strong activity in segments where HCIT is converging with other verticals, including human resources, wellness, compliance, and risk management
- We have completed transactions ranging from $100 million to $2 billion in enterprise value involving both strategic and financing acquirers
- 2019's momentum and our current pipeline point to robust activity in 2020 and beyond
In addition to 2019's activity, we have advised on or underwritten many of the landmark transactions that have shaped the healthcare IT landscape over the past several years. To learn more about our transaction experience, advisory services, and perspective on the trends affecting HCIT, please contact any of our team members.